{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:23:57Z","timestamp":1793773437983,"version":"4.6.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301312"],"award-info":[{"award-number":["82301312"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271158"],"award-info":[{"award-number":["82271158"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23Y11909700"],"award-info":[{"award-number":["23Y11909700"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05350-1","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T02:18:05Z","timestamp":1763518685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacological Inhibition of JAK\/STAT-IL2 Axis Alleviated Cisplatin-Induced Ototoxicity"],"prefix":"10.1007","volume":"63","author":[{"given":"Shimei","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangli","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2248-2237","authenticated-orcid":false,"given":"Yingzi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"5350_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/oxfordjournals.annonc.a058017","volume":"2","author":"PM Goddard","year":"1991","unstructured":"Goddard PM, Valenti MR, Harrap KR (1991) The role of murine tumour models and their acquired platinum-resistant counterparts in the evaluation of novel platinum antitumour agents: a cautionary note. Ann Oncol 2:535\u2013540. https:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a058017","journal-title":"Ann Oncol"},{"key":"5350_CR2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a033548","author":"CJ Kros","year":"2019","unstructured":"Kros CJ, Steyger PS (2019) Aminoglycoside- and cisplatin-induced ototoxicity: mechanisms and otoprotective strategies. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a033548","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5350_CR3","doi-asserted-by":"publisher","first-page":"114045","DOI":"10.1016\/j.bcp.2020.114045","volume":"178","author":"D Dong","year":"2020","unstructured":"Dong D, Yang D, Lin L, Wang S, Wu B (2020) Circadian rhythm in pharmacokinetics and its relevance to chronotherapy. Biochem Pharmacol 178:114045. https:\/\/doi.org\/10.1016\/j.bcp.2020.114045","journal-title":"Biochem Pharmacol"},{"key":"5350_CR4","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/sj.ki.5002786","volume":"73","author":"N Pabla","year":"2008","unstructured":"Pabla N, Dong Z (2008) Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 73:994\u20131007. https:\/\/doi.org\/10.1038\/sj.ki.5002786","journal-title":"Kidney Int"},{"key":"5350_CR5","doi-asserted-by":"publisher","first-page":"e51280","DOI":"10.15252\/embr.202051280","volume":"22","author":"G Babolmorad","year":"2021","unstructured":"Babolmorad G, Latif A, Domingo IK, Pollock NM, Delyea C, Rieger AM, Allison WT, Bhavsar AP (2021) Toll-like receptor 4 is activated by platinum and contributes to cisplatin-induced ototoxicity. EMBO Rep 22:e51280. https:\/\/doi.org\/10.15252\/embr.202051280","journal-title":"EMBO Rep"},{"key":"5350_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00280-013-2304-9","volume":"73","author":"HJ Park","year":"2014","unstructured":"Park HJ, Stokes JA, Corr M, Yaksh TL (2014) Toll-like receptor signaling regulates cisplatin-induced mechanical allodynia in mice. Cancer Chemother Pharmacol 73:25\u201334. https:\/\/doi.org\/10.1007\/s00280-013-2304-9","journal-title":"Cancer Chemother Pharmacol"},{"key":"5350_CR7","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1002\/ejp.679","volume":"19","author":"SA Woller","year":"2015","unstructured":"Woller SA, Corr M, Yaksh TL (2015) Differences in cisplatin-induced mechanical allodynia in male and female mice. Eur J Pain 19:1476\u20131485. https:\/\/doi.org\/10.1002\/ejp.679","journal-title":"Eur J Pain"},{"key":"5350_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","volume":"20","author":"T Gong","year":"2020","unstructured":"Gong T, Liu L, Jiang W, Zhou R (2020) DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat Rev Immunol 20:95\u2013112. https:\/\/doi.org\/10.1038\/s41577-019-0215-7","journal-title":"Nat Rev Immunol"},{"key":"5350_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106210","volume":"80","author":"P Xin","year":"2020","unstructured":"Xin P, Xu X, Deng C, Liu S, Wang Y, Zhou X, Ma H, Wei D et al (2020) The role of JAK\/STAT signaling pathway and its inhibitors in diseases. Int Immunopharmacol 80:106210. https:\/\/doi.org\/10.1016\/j.intimp.2020.106210","journal-title":"Int Immunopharmacol"},{"key":"5350_CR10","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41586-025-09000-3","volume":"643","author":"J Zhou","year":"2025","unstructured":"Zhou J, Tison K, Zhou H, Bai L, Acharyya RK, McEachern D, Metwally H, Wang Y et al (2025) STAT5 and STAT3 balance shapes dendritic cell function and tumour immunity. Nature 643:519\u2013528. https:\/\/doi.org\/10.1038\/s41586-025-09000-3","journal-title":"Nature"},{"key":"5350_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01424","volume":"11","author":"RD Metcalfe","year":"2020","unstructured":"Metcalfe RD, Putoczki TL, Griffin MDW (2020) Structural understanding of interleukin 6 family cytokine signaling and targeted therapies: focus on interleukin 11. Front Immunol 11:1424. https:\/\/doi.org\/10.3389\/fimmu.2020.01424","journal-title":"Front Immunol"},{"key":"5350_CR12","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1365-2567.2009.03244.x","volume":"130","author":"N Chetoui","year":"2010","unstructured":"Chetoui N, Boisvert M, Gendron S, Aoudjit F (2010) Interleukin-7 promotes the survival of human CD4+ effector\/memory T cells by up-regulating Bcl-2 proteins and activating the JAK\/STAT signalling pathway. Immunology 130:418\u2013426. https:\/\/doi.org\/10.1111\/j.1365-2567.2009.03244.x","journal-title":"Immunology"},{"key":"5350_CR13","doi-asserted-by":"publisher","unstructured":"Goleij P, Amini A, Sanaye PM, Heidari MM, Tabari MAK, Aschner M, Larsen DS, Khan H et al (2025) The IL-12 family cytokines in neurodegenerative diseases: dual roles in neurotoxicity and neuroprotection. Inflammopharmacology. https:\/\/doi.org\/10.1007\/s10787-025-01901-z","DOI":"10.1007\/s10787-025-01901-z"},{"key":"5350_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s40272-022-00550-x","volume":"25","author":"S Dhillon","year":"2023","unstructured":"Dhillon S (2023) Sodium thiosulfate: pediatric first approval. Paediatr Drugs 25:239\u2013244. https:\/\/doi.org\/10.1007\/s40272-022-00550-x","journal-title":"Paediatr Drugs"},{"key":"5350_CR15","doi-asserted-by":"publisher","unstructured":"Huarte E, O\u2019Connor RS, Peel MT, Nunez-Cruz S, Leferovich J, Juvekar A, Yang YO, Truong L et al (2020) Itacitinib (INCB039110), a JAK1 inhibitor, reduces cytokines associated with cytokine release syndrome induced by CAR T-cell therapy. Clin Cancer Res 26:6299\u20136309. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-1739","DOI":"10.1158\/1078-0432.CCR-20-1739"},{"key":"5350_CR16","doi-asserted-by":"publisher","unstructured":"Purandare AV, McDevitt TM, Wan H, You D, Penhallow B, Han X, Vuppugalla R, Zhang Y et al (2012) Characterization of BMS-911543, a functionally selective small-molecule inhibitor of JAK2. Leukemia 26:280\u2013288. https:\/\/doi.org\/10.1038\/leu.2011.292","DOI":"10.1038\/leu.2011.292"},{"key":"5350_CR17","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1080\/17425255.2024.2401603","volume":"20","author":"M Nunez","year":"2024","unstructured":"Nunez M, Kar S, Rodriguez KA, Ondieki D (2024) Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata. Expert Opin Drug Metab Toxicol 20:1023\u20131036. https:\/\/doi.org\/10.1080\/17425255.2024.2401603","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"5350_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.955038","volume":"13","author":"Z Dai","year":"2022","unstructured":"Dai Z, Sezin T, Chang Y, Lee EY, Wang EHC, Christiano AM (2022) Induction of T cell exhaustion by JAK1\/3 inhibition in the treatment of alopecia areata. Front Immunol 13:955038. https:\/\/doi.org\/10.3389\/fimmu.2022.955038","journal-title":"Front Immunol"},{"key":"5350_CR19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/ecco-jcc\/jjaa182","volume":"15","author":"MR Spalinger","year":"2021","unstructured":"Spalinger MR, Sayoc-Becerra A, Ordookhanian C, Canale V, Santos AN, King SJ, Krishnan M, Nair MG et al (2021) The JAK inhibitor tofacitinib rescues intestinal barrier defects caused by disrupted epithelial-macrophage interactions. J Crohns Colitis 15:471\u2013484. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa182","journal-title":"J Crohns Colitis"},{"key":"5350_CR20","doi-asserted-by":"publisher","unstructured":"Bonelli M, Kerschbaumer A, Kastrati K, Ghoreschi K, Gadina M, Heinz LX, Smolen JS, Aletaha D et al (2024) Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story. Ann Rheum Dis 83:139\u2013160. https:\/\/doi.org\/10.1136\/ard-2023-223850","DOI":"10.1136\/ard-2023-223850"},{"key":"5350_CR21","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1517\/17460441.2011.562887","volume":"6","author":"D Mukherjea","year":"2011","unstructured":"Mukherjea D, Rybak LP, Sheehan KE, Kaur T, Ramkumar V, Jajoo S, Sheth S (2011) The design and screening of drugs to prevent acquired sensorineural hearing loss. Expert Opin Drug Discov 6:491\u2013505. https:\/\/doi.org\/10.1517\/17460441.2011.562887","journal-title":"Expert Opin Drug Discov"},{"key":"5350_CR22","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.molmed.2019.08.002","volume":"25","author":"E Gentilin","year":"2019","unstructured":"Gentilin E, Simoni E, Candito M, Cazzador D, Astolfi L (2019) Cisplatin-induced ototoxicity: updates on molecular targets. Trends Mol Med 25:1123\u20131132. https:\/\/doi.org\/10.1016\/j.molmed.2019.08.002","journal-title":"Trends Mol Med"},{"key":"5350_CR23","doi-asserted-by":"publisher","unstructured":"Zheng S, Liu C, Tang D, Zheng Z, Yan R, Wu C, Zuo N, Ma J et al (2022) The protective effect of rutin against the cisplatin-induced cochlear damage in vitro. Neurotoxicology 90:102\u2013111. https:\/\/doi.org\/10.1016\/j.neuro.2022.03.005","DOI":"10.1016\/j.neuro.2022.03.005"},{"key":"5350_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13060714","author":"X Gao","year":"2024","unstructured":"Gao X, Mao H, Zhao L, Li X, Liao Y, Li W, Li H, Chen Y (2024) Nuciferine protects cochlear hair cells from ferroptosis through inhibiting NCOA4-mediated ferritinophagy. Antioxidants. https:\/\/doi.org\/10.3390\/antiox13060714","journal-title":"Antioxidants"},{"key":"5350_CR25","doi-asserted-by":"publisher","first-page":"116790","DOI":"10.1016\/j.taap.2023.116790","volume":"482","author":"F Guo","year":"2024","unstructured":"Guo F, Guo Y, Zhang D, Fu Z, Han S, Wan Y, Guan G (2024) Luteolin inhibits the JAK\/STAT pathway to alleviate auditory cell apoptosis of acquired sensorineural hearing loss based on network pharmacology, molecular docking, molecular dynamics simulation, and experiments in vitro. Toxicol Appl Pharmacol 482:116790. https:\/\/doi.org\/10.1016\/j.taap.2023.116790","journal-title":"Toxicol Appl Pharmacol"},{"key":"5350_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108368","volume":"33","author":"S Chakrabarti","year":"2020","unstructured":"Chakrabarti S, Visweswariah SS (2020) Intramacrophage ROS primes the innate immune system via JAK\/STAT and toll activation. Cell Rep 33:108368. https:\/\/doi.org\/10.1016\/j.celrep.2020.108368","journal-title":"Cell Rep"},{"key":"5350_CR27","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s10495-006-6578-9","volume":"11","author":"HM Yu","year":"2006","unstructured":"Yu HM, Zhi JL, Cui Y, Tang EH, Sun SN, Feng JQ, Chen PX (2006) Role of the JAK-STAT pathway in protection of hydrogen peroxide preconditioning against apoptosis induced by oxidative stress in PC12 cells. Apoptosis 11:931\u2013941. https:\/\/doi.org\/10.1007\/s10495-006-6578-9","journal-title":"Apoptosis"},{"key":"5350_CR28","doi-asserted-by":"publisher","first-page":"e1441","DOI":"10.1002\/cti2.1441","volume":"12","author":"Y Cao","year":"2023","unstructured":"Cao Y, Wang J, Jiang S, Lyu M, Zhao F, Liu J, Wang M, Pei X et al (2023) JAK1\/2 inhibitor ruxolitinib promotes the expansion and suppressive action of polymorphonuclear myeloid-derived suppressor cells via the JAK\/STAT and ROS-MAPK\/NF-kappaB signalling pathways in acute graft-versus-host disease. Clin Transl Immunol 12:e1441. https:\/\/doi.org\/10.1002\/cti2.1441","journal-title":"Clin Transl Immunol"},{"key":"5350_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","volume":"38","author":"W Liao","year":"2013","unstructured":"Liao W, Lin JX, Leonard WJ (2013) Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 38:13\u201325. https:\/\/doi.org\/10.1016\/j.immuni.2013.01.004","journal-title":"Immunity"},{"key":"5350_CR30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.immuni.2010.08.004","volume":"33","author":"TR Malek","year":"2010","unstructured":"Malek TR, Castro I (2010) Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity 33:153\u2013165. https:\/\/doi.org\/10.1016\/j.immuni.2010.08.004","journal-title":"Immunity"},{"key":"5350_CR31","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1126\/science.7973659","volume":"266","author":"T Miyazaki","year":"1994","unstructured":"Miyazaki T, Kawahara A, Fujii H, Nakagawa Y, Minami Y, Liu ZJ, Oishi I, Silvennoinen O, Witthuhn BA, Ihle JN et al (1994) Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266:1045\u20131047. https:\/\/doi.org\/10.1126\/science.7973659","journal-title":"Science"},{"key":"5350_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/s1074-7613(00)80097-7","volume":"11","author":"R Moriggl","year":"1999","unstructured":"Moriggl R, Sexl V, Piekorz R, Topham D, Ihle JN (1999) Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells. Immunity 11:225\u2013230. https:\/\/doi.org\/10.1016\/s1074-7613(00)80097-7","journal-title":"Immunity"},{"key":"5350_CR33","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1073\/pnas.93.5.2077","volume":"93","author":"MC Friedmann","year":"1996","unstructured":"Friedmann MC, Migone TS, Russell SM, Leonard WJ (1996) Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc Natl Acad Sci U S A 93:2077\u20132082. https:\/\/doi.org\/10.1073\/pnas.93.5.2077","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5350_CR34","doi-asserted-by":"publisher","first-page":"21381","DOI":"10.1074\/jbc.271.35.21381","volume":"271","author":"SL Gaffen","year":"1996","unstructured":"Gaffen SL, Lai SY, Ha M, Liu X, Hennighausen L, Greene WC, Goldsmith MA (1996) Distinct tyrosine residues within the interleukin-2 receptor beta chain drive signal transduction specificity, redundancy, and diversity. J Biol Chem 271:21381\u201321390. https:\/\/doi.org\/10.1074\/jbc.271.35.21381","journal-title":"J Biol Chem"},{"key":"5350_CR35","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/1074-7613(95)90140-x","volume":"2","author":"J Hou","year":"1995","unstructured":"Hou J, Schindler U, Henzel WJ, Wong SC, McKnight SL (1995) Identification and purification of human Stat proteins activated in response to interleukin-2. Immunity 2:321\u2013329. https:\/\/doi.org\/10.1016\/1074-7613(95)90140-x","journal-title":"Immunity"},{"key":"5350_CR36","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/1074-7613(95)90141-8","volume":"2","author":"JX Lin","year":"1995","unstructured":"Lin JX, Migone TS, Tsang M, Friedmann M, Weatherbee JA, Zhou L, Yamauchi A, Bloom ET et al (1995) The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:331\u2013339. https:\/\/doi.org\/10.1016\/1074-7613(95)90141-8","journal-title":"Immunity"},{"key":"5350_CR37","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1002\/j.1460-2075.1996.tb00541.x","volume":"15","author":"C Beadling","year":"1996","unstructured":"Beadling C, Ng J, Babbage JW, Cantrell DA (1996) Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine\/threonine kinase pathway distinct from the Raf1\/ERK2 MAP kinase pathway. EMBO J 15:1902\u20131913","journal-title":"EMBO J"},{"key":"5350_CR38","doi-asserted-by":"publisher","first-page":"8705","DOI":"10.1073\/pnas.92.19.8705","volume":"92","author":"JA Johnston","year":"1995","unstructured":"Johnston JA, Bacon CM, Finbloom DS, Rees RC, Kaplan D, Shibuya K, Ortaldo JR, Gupta S, Chen YQ, Giri JD et al (1995) Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc Natl Acad Sci U S A 92:8705\u20138709. https:\/\/doi.org\/10.1073\/pnas.92.19.8705","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5350_CR39","doi-asserted-by":"publisher","first-page":"9080","DOI":"10.1128\/JVI.00983-15","volume":"89","author":"T Shigemura","year":"2015","unstructured":"Shigemura T, Shiohara M, Kato M, Furuta S, Kaneda K, Morishita K, Hasegawa H, Fujii M et al (2015) Superoxide-generating Nox5alpha is functionally required for the human T-cell leukemia virus type 1-induced cell transformation phenotype. J Virol 89:9080\u20139089. https:\/\/doi.org\/10.1128\/JVI.00983-15","journal-title":"J Virol"},{"key":"5350_CR40","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4049\/jimmunol.1701133","volume":"200","author":"SS Majri","year":"2018","unstructured":"Majri SS, Fritz JM, Villarino AV, Zheng L, Kanellopoulou C, Chaigne-Delalande B, Gronholm J, Niemela JE et al (2018) STAT5B: a differential regulator of the life and death of CD4(+) effector memory T cells. J Immunol 200:110\u2013118. https:\/\/doi.org\/10.4049\/jimmunol.1701133","journal-title":"J Immunol"},{"key":"5350_CR41","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1182\/blood.2022017442","volume":"141","author":"A Etra","year":"2023","unstructured":"Etra A, Capellini A, Alousi A, Al Malki MM, Choe H, DeFilipp Z, Hogan WJ, Kitko CL et al (2023) Effective treatment of low-risk acute GVHD with itacitinib monotherapy. Blood 141:481\u2013489. https:\/\/doi.org\/10.1182\/blood.2022017442","journal-title":"Blood"},{"key":"5350_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00780-9","volume":"13","author":"N Gangat","year":"2023","unstructured":"Gangat N, Begna KH, Al-Kali A, Hogan W, Litzow M, Pardanani A, Tefferi A (2023) Determinants of survival and retrospective comparisons of 183 clinical trial patients with myelofibrosis treated with momelotinib, ruxolitinib, fedratinib or BMS-911543 JAK2 inhibitor. Blood Cancer J 13:3. https:\/\/doi.org\/10.1038\/s41408-022-00780-9","journal-title":"Blood Cancer J"},{"key":"5350_CR43","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s40265-023-01928-y","volume":"83","author":"HA Blair","year":"2023","unstructured":"Blair HA (2023) Ritlecitinib: first approval. Drugs 83:1315\u20131321. https:\/\/doi.org\/10.1007\/s40265-023-01928-y","journal-title":"Drugs"},{"key":"5350_CR44","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","volume":"77","author":"S Banerjee","year":"2017","unstructured":"Banerjee S, Biehl A, Gadina M, Hasni S, Schwartz DM (2017) Jak-stat signaling as a target for inflammatory and autoimmune diseases: current and future prospects. Drugs 77:521\u2013546. https:\/\/doi.org\/10.1007\/s40265-017-0701-9","journal-title":"Drugs"},{"key":"5350_CR45","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.gendis.2018.06.001","volume":"5","author":"Y Hou","year":"2018","unstructured":"Hou Y, Wang K, Wan W, Cheng Y, Pu X, Ye X (2018) Resveratrol provides neuroprotection by regulating the JAK2\/STAT3\/PI3K\/AKT\/mTOR pathway after stroke in rats. Genes Dis 5:245\u2013255. https:\/\/doi.org\/10.1016\/j.gendis.2018.06.001","journal-title":"Genes Dis"},{"key":"5350_CR46","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/35088074","volume":"412","author":"M Digicaylioglu","year":"2001","unstructured":"Digicaylioglu M, Lipton SA (2001) Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412:641\u2013647. https:\/\/doi.org\/10.1038\/35088074","journal-title":"Nature"},{"key":"5350_CR47","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.ymthe.2024.02.029","volume":"32","author":"Z Liu","year":"2024","unstructured":"Liu Z, Zhang H, Hong G, Bi X, Hu J, Zhang T, An Y, Guo N et al (2024) Inhibition of Gpx4-mediated ferroptosis alleviates cisplatin-induced hearing loss in C57BL\/6 mice. Mol Ther 32:1387\u20131406. https:\/\/doi.org\/10.1016\/j.ymthe.2024.02.029","journal-title":"Mol Ther"},{"key":"5350_CR48","doi-asserted-by":"publisher","first-page":"e2402671","DOI":"10.1002\/advs.202402671","volume":"11","author":"X Wang","year":"2024","unstructured":"Wang X, Xu L, Meng Y, Chen F, Zhuang J, Wang M, An W, Han Y et al (2024) FOXO1-NCOA4 axis contributes to cisplatin-induced cochlea spiral ganglion neuron ferroptosis via ferritinophagy. Adv Sci (Weinh) 11:e2402671. https:\/\/doi.org\/10.1002\/advs.202402671","journal-title":"Adv Sci (Weinh)"},{"key":"5350_CR49","doi-asserted-by":"publisher","unstructured":"Guo Z, Wu Y, Chen B, Kong M, Xie P, Li Y, Liu D, Chai R et al (2024) Superparamagnetic iron oxide nanoparticle regulates microbiota-gut-inner ear axis for hearing protection. Natl Sci Rev 11:nwae100. https:\/\/doi.org\/10.1093\/nsr\/nwae100","DOI":"10.1093\/nsr\/nwae100"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05350-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05350-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05350-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T02:18:16Z","timestamp":1763518696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05350-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5350"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05350-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"27 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiments and protocols were performed in strict accordance with the Institutional Review Boards and Animal Care and Use Committees of Fudan University (approval number: IACUC-DWZX-2023-031).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"83"}}